Energy balance and cancer: The role of insulin and insulin-like growth factor-I

Proceedings of the Nutrition Society

Volumn 60, Issue 1, 2001, Pages 91-106

  Kaaks, R ^a   Lukanova, A ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Cancer; Energy balance; Insulin; Insulin like growth factors

Indexed keywords

INSULIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CANCER; CANCER RISK; CARCINOGENESIS; CORRELATION FUNCTION; ENERGY BALANCE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPERINSULINEMIA; OBESITY; PHYSICAL ACTIVITY;

EID: 0035123520     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS200070     Document Type: Article

References (235)

1. Insulin resistance and obesity. The role of fat distribution pattern
2. Cancer risk in patients with diabetes mellitus
3. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: Effect of short- and long-term weight recuperation
4. Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women with endometrial cancer
5. Anthropometry and breast cancer. Body size - A moving target
6. Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency
7. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects
8. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
9. Effect of body weight reduction on plasma androgens in obese, infertile women
10. Growth hormone-binding proteins in plasma
11. The effect of fasting on liver receptors for prolactin and growth hormone
12. Regulation of hepatic growth hormone receptors by insulin
13. Regulation of testicular function by insulin and transforming growth factor-beta
14. Insulin resistance in obesity: Metabolic mechanisms and measurement methods
15. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity
16. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus
17. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus
18. Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects
19. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: Evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations
20. Endogenous hormones and breast cancer risk
21. Abdominal obesity and the metabolic syndrome
22. Fatty acids, hyperinsulinemia, and insulin resistance: Which comes first?
23. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast
24. Overexpression of insulin-like growth factor-I induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice
25. Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes
26. Influence of acute and chronic exercise on insulin-like growth factor-I in healthy active elderly men and women
27. Insulin resistance and breast-cancer risk
28. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer
29. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults
30. Effect of brief exercise on circulating insulin-like growth factor I
31. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production
32. Physiology of growth hormone secretion and action
33. Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects
34. Influence of physical activity on plasma insulin-like growth factor-I and insulin-like growth factor binding proteins in healthy older women
35. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
36. Hormonal changes in elderly men with non-insulin-dependent diabetes mellitus and the hormonal relationships to abdominal adiposity
37. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I
38. Transcriptional regulation of the lutropin/human choriogonadotropin receptor and three enzymes of steroidogenesis by growth factors in cultured pig Leydig cells
39. Reduction of plasma immunoreactive somatomedin C during fasting in humans
40. Nutritional regulation of IGF-I and IGF binding proteins
41. Physical activity and reduced risk of colon cancer: Implications for prevention
42. Insulin regulation of insulin-like growth factor-binding protein production in cultured HepG2 cells
43. The relationship between insulin-like growth factor-I, adiposity, and aging
44. Study of insulin-like growth factor I in human obesity
45. Chronic anovulation syndrome and associated neoplasia
46. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
47. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells
48. Regulation of prostatic growth and function by peptide growth factors
49. Endometrial carcinoma; ovarian dysfunction - A risk factor in young women
50. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
51. Insulin and related factors in premenopausal breast cancer risk
52. Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells
53. Insulin-like growth factor-I-mediated amplification of follicle-stimulating hormone-supported progesterone accumulation by cultured rat granulosa cells: Enhancement of steroidogenic enzyme activity and expression
54. Growth factors in breast cancer
55. Constitutive expression of insulin-like growth factor-I in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion
56. Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice
57. Growth hormone and insulin-like growth factor I responses to moderate submaximal acute physical exercise in man: Effects of octreotide, a somatostatin analogue, administration
58. Insulin action in the polycystic ovary syndrome
59. Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus
60. Endogenous sex hormones and prostate cancer: A quantitative review of prospective studies
61. Insulin-lowering therapeutic modalities for polycystic ovary, syndrome
62. Increased physical activity and the growth hormone-IGF-I axis in adolescent males
63. Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise
64. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men
65. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis
66. Hyperinsulinism and sex hormones in young adult African Americans
67. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men
68. Caloric restriction as a mechanism mediating resistance to environmental disease
69. Risk factors for pancreatic cancer: An exploratory study
70. Free insulin-like growth factors in human obesity
71. The effect of synthetic very low calorie diets on the GH-IGF-1 axis in obese subjects
72. Recreational and occupational physical activities and risk of breast cancer
73. Abnormal glucose metabolism and pancreatic cancer mortality
74. Energy intake, overweight, physical exercise and colorectal cancer risk
75. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
76. Insulin and colon cancer
77. A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women
78. Diabetes mellitus and risk of prostate cancer
79. Influence of thyroid hormones on the regulation of growth hormone secretion
80. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa
81. Diet, body size, physical activity, and the risk of endometrial cancer
82. Endometrial Cancer
83. Interaction of physical activity and diet: Implications for insulin-glucose dynamics
84. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone
85. Insulin resistance, body fat distribution, and sex hormones in men
86. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men
87. Obesity, body fat distribution and sex hormones in men
88. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
89. Nutrition and endometrial cancer
90. Sex steroid regulation of growth hormone secretion and action
91. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa
92. Changes in circulating insulin-like growth factor-binding protein-I (IGFBP-I) during prolonged exercise: Effect of carbohydrate feeding
93. Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women
94. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
95. Body composition assessed by bioelectrical impedance analysis (BIA) and the correlation with plasma insulin-like growth factor I (IGF-I) in normal Japanese subjects and patients with acromegaly and GH deficiency
96. Diet, body size, and breast cancer
97. Influence of intensive exercise on insulin-like growth factor I, thyroid and steroid hormones in female gymnasts
98. Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score
99. Anthropometric and reproductive factors and the risk of pancreatic cancer: A case-control study in Shanghai, China
100. Insulin-like growth factors and their binding proteins: Biological actions
101. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty
102. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
103. Nutrition, hormones, and breast cancer: Is insulin the missing link?
104. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins and colorectal cancer risk in women
105. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in ishikawa endometrial cancer cells
106. Energy balance and cancer: The role of sex hormones
107. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
108. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
109. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-I
110. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels
111. Physical training and insulin sensitivity
112. Nutrition and prostate cancer
113. The effect of weight loss on sex steroid secretion and binding in massively obese women
114. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training
115. Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise
116. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells
117. Caloric restriction and experimental carcinogenesis
118. Diabetes mellitus and colorectal cancer risk
119. A case-control study of diabetes mellitus and cancer risk
120. IGF system components as prognostic markers in breast cancer
121. Insulin-like growth factor binding protein-1: Recent findings and new directions
122. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
123. Direct stimulatory effects of insulin-like growth factor-I on Leydig cell steroidogenesis in primary culture
124. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients
125. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?
126. Physical activity and cancer etiology: Associations and mechanisms
127. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
128. Low plasma somatomedin-C in streptozotocin-induced diabetes mellitus. Correlation with changes in somatogenic and lactogenic liver binding sites
129. Insulin-like growth factor-I selectively stimulates cholesterol side-chain cleavage expression in ovarian theca-interstitial cells
130. Differentiation of ovarian theca-interstitial cells in vitro: Regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I
131. Insulin-like growth factor-I stimulates the expression of 3 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid in ovarian theca-interstitial cells
132. IGF-I and IGF-II in relation to colorectal cancer
133. Insulin-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia
134. Low concentrations of insulin-like growth factor-I in abdominal obesity
135. Characteristics of the somatotropic axis in insulin dependent diabetes mellitus
136. Insulin-like growth factors in the fed and fasted states
137. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: Implications for adrenal androgen regulation
138. Obesity and cancer risk: A Danish record-linkage study
139. Physical exercise: A pillar for cancer prevention?
140. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: Common and distinct features
141. The influence of medical conditions associated with hormones on the risk of breast cancer
142. Effect of obesity on total and free insulin-like growth factor (IGF)-I, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
143. Influence of exercise duration on serum insulin-like growth factor and its binding proteins in athletes
144. Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 55-70 years
145. A case-control study of uterine endometrial cancer of pre- and post-menopausal women
146. Free insulin-like growth factor I (IGF-I) in healthy subjects: Relationship with IGF-binding proteins and insulin sensitivity
147. Diabetes mellitus and cancer risk: A multisite case-control study
148. Diabetes and endometrial cancer: An Italian case-control study
149. Effect of obesity and body fat distribution on sex hormones and insulin in men
150. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome
151. Regulation of primary response and specific genes in adrenal cells by peptide hormones and growth factors
152. Leptin and insulin growth factor I in relation to breast cancer (Greece)
153. Plasma insulin-like growth factor-I (IGF-I) concentrations in human breast cancer
154. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women
155. Regulation of sex hormone binding globulin (SHBG) production in Hep G2 cells by insulin
156. The insulin-related ovarian regulatory system in health and disease
157. Growth hormone receptors in rat liver membranes: Effects of fasting and refeeding, and correlation with plasma somatomedin activity
158. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant
159. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries
160. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
161. Insulin resistance, polycystic ovary syndrome and metformin
162. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
163. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53- and IGF-independent mechanism
164. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
165. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-I (IGF-1), IGF-binding protein-3, insulin, and growth hormone
166. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects
167. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity
168. Growth inhibition by insulin-like growth factor (IGF) binding protein-3 - What's IGF got to do with it?
169. Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training
170. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
171. Insulin-like growth factors in endometrial function
172. Suppressed expression of insulin-like growth factor binding protein-I mRNA in the endometrium: A molecular mechanism associating endometrial cancer with its risk factors
173. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
174. Effect of exercise on cytokines and growth mediators in prepubertal children
175. Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis
176. Increased blood glucose and insulin, body size, and incident colorectal cancer
177. Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men
178. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels
179. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer
180. Diabetes, body size, and risk of endometrial cancer
181. A population-based case-control study of endometrial cancer in Shanghai, China
182. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
183. Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews
184. Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells
185. Insulinlike growth factors and binding proteins in colon cancer
186. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
187. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: A prospective study
188. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: Diabetes, cholesterol, pulse and physical activity
189. In vivo regulation of the steroidogenic activity of rat luteal cells by insulin
190. Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors
191. Nutritional regulation of hormones and growth factors that control mammalian growth
192. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver
193. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein
194. Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements
195. Changes in somatomedin activity in anorexia nervosa
196. Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation via brain
197. Nutritional regulation of the insulin-like growth factors
198. Endogenous estrogen and postmenopausal breast cancer: A quantitative review
199. The pituitary-gonadal axis and health in elderly men: A study of men born in 1913
200. Growth hormone (GH) regulation of cytochrome P-450IIC12, insulin-like growth factor-I (IGF-I), and GH receptor messenger RNA expression in primary rat hepatocytes: A hormonal interplay with insulin, IGF-I, and thyroid hormone
201. Serum insulin-like growth factor-I and breast cancer
202. Insulin and endometrial cancer
203. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit
204. Insulin-like growth factor binding protein-1: Identification, purification, and regulation in fetal and adult life
205. Insulin-like growth factor type I increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary, cultures of porcine granulosa cells
206. A meta-analysis of body mass index and risk of premenopausal breast cancer
207. Growth hormone and nutrition
208. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay
209. Decreased androgen levels and obesity in men
210. Testosterone, body composition and aging
211. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males
212. Successful 6-month endurance training does not alter insulin-like growth factor-I in healthy older men and women
213. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls
214. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult makes: A potential test for GH abuse in sport
215. Basic counterpoint: Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion
216. Risk of endometrial and breast cancer in patients with diabetes mellitus
217. Occurrence, trends and environment etiology of pancreatic cancer
218. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer
219. Effect of caloric restriction on age-associated cancers
220. Breast cancer risk in young women and history of selected medical conditions
221. The role of the insulin-like growth factor system in human cancer
222. Effects of gender on exercise-induced growth hormone release
223. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
224. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-I receptor in the epidermis of transgenic mice
225. Colorectal cancer: Another complication of diabetes mellitus?
226. Is diabetes mellitus associated with prostate cancer incidence and survival?
227. Clinical actions of growth hormone
228. Role of dihydrotestosterone in androgen action
229. Insulin-like growth factor I and prostate cancer risk: A population-based, case-control study
230. Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada
231. Breast cancer among former college athletes compared to non-athletes: A 15-year follow-up
232. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation